LifeMD, Inc.: Form 10-Q for the period ended Sep 30, 2015
Filed with the SEC on Nov 13, 2015 and accepted by EDGAR at Nov 13, 2015, 16:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-07-01 to 2015-09-30 | $279.9k | us-gaap:Revenues |
| Revenue | 9 months2015-01-01 to 2015-09-30 | $845.5k | us-gaap:Revenues |
| Cost of revenue | 3 months2015-07-01 to 2015-09-30 | $74.0k | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2015-01-01 to 2015-09-30 | $237.7k | us-gaap:CostOfRevenue |
| Gross profit | 3 months2015-07-01 to 2015-09-30 | $205.9k | us-gaap:GrossProfit |
| Gross profit | 9 months2015-01-01 to 2015-09-30 | $607.8k | us-gaap:GrossProfit |
| Operating income | 3 months2015-07-01 to 2015-09-30 | $17.9k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2015-01-01 to 2015-09-30 | $8.6k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2015-07-01 to 2015-09-30 | $14.4k | us-gaap:InterestExpense |
| Interest expense | 9 months2015-01-01 to 2015-09-30 | $33.0k | us-gaap:InterestExpense |
| Net income | 3 months2015-07-01 to 2015-09-30 | $8.1k | us-gaap:NetIncomeLoss |
| Net income | 9 months2015-01-01 to 2015-09-30 | −$11.2k | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months2015-07-01 to 2015-09-30 | 30,609,973 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2015-01-01 to 2015-09-30 | 30,663,306 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2015-01-01 to 2015-09-30 | −$80.3k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 9 months2015-01-01 to 2015-09-30 | $10.8k | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2015-09-30 | $73.9k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-09-30 | $245.0k | us-gaap:AssetsCurrent |
| Total assets | At period end2015-09-30 | $245.0k | us-gaap:Assets |
| Current liabilities | At period end2015-09-30 | $381.9k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-09-30 | $381.9k | us-gaap:Liabilities |
| Shareholders' equity | At period end2015-09-30 | −$136.8k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-15-008584. Last ingested by Listed: Nov 13, 2026, 16:33 ET. Listed shows no prices and gives no investment advice.